Hyaluronic acid/Fluorouracil

透明质酸/氟尿嘧啶

Report date: 2022/10/19 15:11:59

Base Information

Drug NameHyaluronic acid/Fluorouracil
Drug Alias Name氟尿嘧啶/透明质酸Fluorouracil+Hyaluronic acidHA-Fluorouracil透明质酸+氟尿嘧啶氟尿嘧啶+透明质酸 +[13] 
ClassificationSmall molecules
Mechanisms of ActionCD44 antigen modulatorsThymidylate synthase inhibitors
TargetsCD44 antigenThymidylate synthase
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes FluorouracilHyaluronic acid inhalation (Actelion Pharmaceuticals)
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMonash UniversityAlchemia Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMonash UniversityAlchemia Ltd
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A